The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Performance status, survival, and end-of-life care in adults with non-small cell lung cancer (NSCLC) treated with immunotherapy.
 
Laura A. Petrillo
No Relationships to Disclose
 
Areej El-Jawahri
No Relationships to Disclose
 
Ryan David Nipp
No Relationships to Disclose
 
Morgan Lichtenstein
No Relationships to Disclose
 
Kerry Lynn Reynolds
No Relationships to Disclose
 
Joseph Greer
Consulting or Advisory Role - Vector Oncology
Research Funding - Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Springer Publishing Company for edited book, "The Massachusetts General Hospital Handbook of Behavioral Medicine."
 
Jennifer S. Temel
Research Funding - Pfizer (Inst)
 
Justin F. Gainor
Employment - Ironwood Pharmaceuticals (I)
Honoraria - ARIAD; Incyte; Merck; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Agios; Amgen; Array BioPharma; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Jounce Therapeutics; Loxo; Merck; Oncorus; Regeneron; Takeda; Theravance
Research Funding - Adaptimmune (Inst); Alexo Therapeutics (Inst); ARIAD; Array BioPharma (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb (Inst); Genentech; Jounce Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Novartis (Inst); Tesaro (Inst)